Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
British Medical Journal
|
June 18, 1977
Clinics in general practice. A case for the gynaecologist?
K G Dickinson, R M Adam
In Vitro Cellular & Developmental Biology. Animal
|
August 23, 2001
A novel method for implantation of LNCaP prostate tumor cells under the renal capsule
R M Adam, A Orsola, M R Freeman
Growth Factors (Chur, Switzerland)
|
January 1, 1996
Induction of anchorage-independent growth by amphiregulin
R M Adam, S G Chamberlin, D E Davies
BMJ (Clinical Research Ed.)
|
July 18, 1992
Potential endocervical pathogens before termination
J C Konje, P N Hooker, R M Adam
Cancer Research
|
June 26, 1999
The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
J Lin, R M Adam, E Santiestevan, et al.
Journal of Dental Research
|
July 24, 2004
Mechanical strain delivers anti-apoptotic and proliferative signals to gingival fibroblasts
T E Danciu, E Gagari, R M Adam, et al.
Journal of Cellular Biochemistry
|
April 21, 1998
Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C
S M Dethlefsen, G Raab, M A Moses, et al.
The Journal of Urology
|
December 23, 2000
Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro
J L Duque, R M Adam, J S Mullen, et al.
Endocrinology
|
December 1, 1999
Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate
R M Adam, J G Borer, J Williams, et al.
Urology
|
September 4, 1999
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
J L Duque, K R Loughlin, R M Adam, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
British Medical Journal
|
June 18, 1977
Clinics in general practice. A case for the gynaecologist?
K G Dickinson, R M Adam
In Vitro Cellular & Developmental Biology. Animal
|
August 23, 2001
A novel method for implantation of LNCaP prostate tumor cells under the renal capsule
R M Adam, A Orsola, M R Freeman
Growth Factors (Chur, Switzerland)
|
January 1, 1996
Induction of anchorage-independent growth by amphiregulin
R M Adam, S G Chamberlin, D E Davies
BMJ (Clinical Research Ed.)
|
July 18, 1992
Potential endocervical pathogens before termination
J C Konje, P N Hooker, R M Adam
Cancer Research
|
June 26, 1999
The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
J Lin, R M Adam, E Santiestevan, et al.
Journal of Dental Research
|
July 24, 2004
Mechanical strain delivers anti-apoptotic and proliferative signals to gingival fibroblasts
T E Danciu, E Gagari, R M Adam, et al.
Journal of Cellular Biochemistry
|
April 21, 1998
Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C
S M Dethlefsen, G Raab, M A Moses, et al.
The Journal of Urology
|
December 23, 2000
Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro
J L Duque, R M Adam, J S Mullen, et al.
Endocrinology
|
December 1, 1999
Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate
R M Adam, J G Borer, J Williams, et al.
Urology
|
September 4, 1999
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
J L Duque, K R Loughlin, R M Adam, et al.
Page
of 2